<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04594421</url>
  </required_header>
  <id_info>
    <org_study_id>Eosinophil increase</org_study_id>
    <nct_id>NCT04594421</nct_id>
  </id_info>
  <brief_title>Change Trend of Effluent Eosinophil During Peritoneal Dialysis-Related Peritonitis</brief_title>
  <official_title>Study on the Increasing Proportion and Change Trend of Eosinophil in Peritoneal Fluid During Peritoneal Dialysis-Related Peritonitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center prospective cohort study will be conducted to explore the change trend of&#xD;
      eosinophil in peritoneal dialysis effluent during peritoneal dialysis-associated peritonitis,&#xD;
      and to explore the relationship between eosinophil increase, peritonitis severity and&#xD;
      antibiotic use. This study will provide evidence for routine eosinophil testing&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multi-center prospective cohort study will be conducted to explore the change trend of&#xD;
      eosinophil in peritoneal dialysis effluent during peritoneal dialysis-associated peritonitis,&#xD;
      and to explore the relationship between eosinophil increase, peritonitis severity and&#xD;
      antibiotic use. In this study, 100 patients with peritoneal dialysis-associated peritonitis&#xD;
      who meet the inclusion criteria will be selected. Demographic data, laboratory variables,&#xD;
      peritoneal fluid cytology and bacterial culture will be collected within 24 hours of&#xD;
      peritonitis (day 1). Peritoneal fluid cytology includes leukocyte classification and&#xD;
      eosinophilic leukocyte count will be examined at day 3, 5, 7, 10, 14, 21, 30, 60 and 90 after&#xD;
      peritonitis. All patients will be followed up for 90 days, and their peritonitis outcome will&#xD;
      be recorded. The primary endpoint is the prevalence of eosinophil increase in peritoneal&#xD;
      effluent, which is defined as &gt;100 eosinophils/mm3, or &gt;10% eosinophils of the total&#xD;
      non-erythrocyte count. Secondary end points are peritonitis outcome at month 1 and 3&#xD;
      including transfer to hemodialysis , death and continue on peritoneal dialysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of elevated eosinophils in peritoneal dialysis effluent</measure>
    <time_frame>June 1,2020 to December 31,2021</time_frame>
    <description>eosinophil number &gt;100 /mm3, or the proportion of polynuclear leukocytes &gt;10%.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peritonitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients on peritoneal dialysis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed as peritoneal dialysis-related peritonitis;&#xD;
&#xD;
          -  Age&gt; 14 years&#xD;
&#xD;
          -  Maintenance peritoneal dialysis due to end-stage renal failure â‰¥3 months&#xD;
&#xD;
          -  Use of lactate glucose dialysate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those who cannot be followed up regularly&#xD;
&#xD;
          -  Reluctant to join this researcher&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tiantian Ma</last_name>
    <phone>15201286467</phone>
    <email>matiantian1986@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renal Division and Institute of Nehprology,Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Dong, MD</last_name>
      <phone>086-010-83572388</phone>
      <email>jie.dong@bjmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Dong Jie</investigator_full_name>
    <investigator_title>Professor in Renal Divison,Department of Medicine</investigator_title>
  </responsible_party>
  <keyword>Peritonitis</keyword>
  <keyword>eosinophil</keyword>
  <keyword>peritoneal dialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

